Julie E Lang (Julie Lang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Circulating Tumor

Metastatic Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Annals of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Pushpinder Kaur, Alexander Ring, Tania B Porras, Guang Zhou, Janice Lu, Irene Kang, Julie E Lang
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes. Cancers 16 (3) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Pushpinder Kaur, Alexander Ring, Tania B Porras, Guang Zhou, Janice Lu, Irene Kang, Julie E Lang
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes. Cancers 16 (3) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Monica N Khattak, Anna M Chichura, Julie E Lang
Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial. Annals of surgical oncology 31 (3) (2023)
Monica N Khattak, Anna M Chichura, Julie E Lang
Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial. Annals of surgical oncology 31 (3) (2023)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Monica N Khattak, Anna M Chichura, Julie E Lang
Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial. Annals of surgical oncology (2023)
Monica N Khattak, Anna M Chichura, Julie E Lang
Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial. Annals of surgical oncology 31 (3) (2023)
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Erin D Ellis, Heather Beckwith, Barbara B Haley, Anthony D Elias, Judy C Boughey, Rachel L Yung, Claudine Isaacs, Amy S Clark, Hyo S Han, Rita Nanda, Qamar J Khan, Kristen K Edmiston, Erica Stringer-Reasor, Elissa Price, Bonnie Joe, Minetta C Liu, Lamorna Brown Swigart, Emanuel F Petricoin, Julia D Wulfkuhle, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Adam L Asare, Jeffrey B Matthews, Michelle Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Nola M Hylton, Angela M DeMichele, Donald A Berry, Laura J Esserman
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. NPJ breast cancer 8 (1) (2022)
Evan N Cohen, Gitanjali Jayachandran, Richard G Moore, Massimo Cristofanilli, Julie E Lang, Joseph D Khoury, Michael F Press, Kyu Kwang Kim, Negar Khazan, Qiang Zhang, Youbin Zhang, Pushpinder Kaur, Roberta Guzman, Michael C Miller, James M Reuben, Naoto Tada Ueno
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix ® PC1 System. Cancers 14 (21) (2022)
Amy S Clark, Christina Yau, Denise M Wolf, Emanuel F Petricoin, Laura van 't Veer, Douglas Yee, Stacy L Moulder, Anne M Wallace, A Jo Chien, Claudine Isaacs, Judy C Boughey, Kathy S Albain, Kathleen Kemmer, Barbara B Haley, Hyo S Han, Andres Forero-Torres, Anthony Elias, Julie E Lang, Erin D Ellis, Rachel Yung, Debasish Tripathy, Rita Nanda, Julia D Wulfkuhle, Lamorna Brown Swigart, Rosa I Gallagher, Teresa Helsten, Erin Roesch, Cheryl A Ewing, Michael Alvarado, Erin P Crane, Meredith Buxton, Julia L Clennell, Melissa Paoloni, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Katherine Steeg, Adam Asare, Jeffrey B Matthews, Scott Berry, Ashish Sanil, Michelle Melisko, Jane Perlmutter, Hope S Rugo, Richard B Schwab, William Fraser Symmans, Nola M Hylton, Donald A Berry, Laura J Esserman, Angela M DeMichele
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. Nature communications 12 (1) (2021)
Pushpinder Kaur, Tania B Porras, Anthony Colombo, Alexander Ring, Janice Lu, Irene Kang, Julie E Lang
Identification of putative actionable alterations in clinically relevant genes in breast cancer. British journal of cancer 125 (9) (2021)
Pushpinder Kaur, Daniel Campo, Tania B Porras, Alexander Ring, Janice Lu, Yvonne Chairez, Yunyun Su, Irene Kang, Julie E Lang
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer. International journal of molecular sciences 21 (14) (2020)
Julie Wecsler, Young Ju Jeong, Akshara S Raghavendra, Wendy J Mack, Debasish Tripathy, Mary W Yamashita, Pulin A Sheth, Linda Hovanessian Larsen, Christy A Russell, Heather MacDonald, Stephen F Sener, Julie E Lang
Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers. Journal of surgical oncology 121 (4) (2020)
Jennifer L Caswell-Jin, Katherine L McNamara, Johannes G Reiter, Ruping Sun, Zheng Hu, Zhicheng Ma, Jie Ding, Carlos J Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte, Suet-Feung Chin, Helen Bardwell, Elena Provenzano, Carlos Caldas, Julie E Lang, Robert West, Debasish Tripathy, Michael F Press, Christina Curtis
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy. Nature communications 10 (1) (2019)
Stephen F Sener, Rachel E Sargent, Connie Lee, Tejas Manchandia, Vivian Le-Tran, Yuliya Olimpiadi, Nicole Zaremba, Andrew Alabd, Maria Nelson, Julie E Lang
MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer. Journal of surgical oncology 120 (6) (2019)
Anson Snow, Denaly Chen, Julie E Lang
The current status of the clinical utility of liquid biopsies in cancer. Expert review of molecular diagnostics 19 (11) (2019)
Jennifer L Caswell-Jin, Katherine L McNamara, Johannes G Reiter, Ruping Sun, Zheng Hu, Zhicheng Ma, Jie Ding, Carlos J Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte, Suet-Feung Chin, Helen Bardwell, Elena Provenzano, Carlos Caldas, Julie E Lang, Robert West, Debasish Tripathy, Michael F Press, Christina Curtis
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy. Nature communications 10 (1) (2019)
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, W Fraser Symmans, Rita Mukhtar, Jasmine M Wong, Cheryl A Ewing, David A Potter, Todd M Tuttle, Tina J Hieken, Jodi M Carter, James W Jakub, Henry G Kaplan, Claire L Buchanan, Nora T Jaskowiak, Husain A Sattar, Jeffrey Mueller, Rita Nanda, Claudine J Isaacs, Paula R Pohlmann, Filipa Lynce, Eleni A Tousimis, Jay C Zeck, M Catherine Lee, Julie E Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin M Kalinsky, Hanina Hibshoosh, Brigid Killelea, Tara Sanft, Gillian L Hirst, Smita Asare, Jeffrey B Matthews, Jane Perlmutter, Laura J Esserman, null null
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ breast cancer 4 (2018)
Oihana Iriondo, Yarong Liu, Grace Lee, Mostafa Elhodaky, Christian Jimenez, Lin Li, Julie E Lang, Pin Wang, Min Yu
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nature communications 9 (1) (2018)